Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Banks

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Advances in Pharmacological Sciences|December 18, 2012
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-AdministrationMatthew L Banks, S Stevens Negus
Neuropharmacology|June 11, 2013
Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimagingMichael A Nader, Matthew L Banks
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2021
Adding dopamine to the complexity of sex differences in opioid reinforcementHannah L Robinson, Matthew L Banks
Experimental and Clinical Psychopharmacology|April 23, 2019
Effects of repeated kappa-opioid receptor agonist U-50488 treatment and subsequent termination on intracranial self-stimulation in male and female ratsKaycee E Faunce, Matthew L Banks
Cold Spring Harbor Perspectives in Medicine|November 6, 2012
Medications development for opioid abuseS Stevens Negus, Matthew L Banks
Psychopharmacology|June 20, 2023
Effects of environmental and pharmacological manipulations on cocaine-vs-negative reinforcer choice in male and female ratsMadison M Marcus, Matthew L Banks
Experimental and Clinical Psychopharmacology|December 19, 2017
Remifentanil maintains lower initial delayed nonmatching-to-sample accuracy compared to food pellets in male rhesus monkeysBlake A Hutsell, Matthew L Banks
Pharmacology, Biochemistry, and Behavior|April 27, 2017
Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications developmentS Stevens Negus, Matthew L Banks
Addiction Biology|February 21, 2024
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorderMatthew L Banks, Jon E Sprague
Drug and Alcohol Dependence|March 26, 2026
Effects of nonpharmacological manipulations and repeated xanomeline treatment on methamphetamine-vs-food choice in Sprague Dawley and Long Evans ratsAmber N Baldwin, Matthew L Banks
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Advances in Pharmacological Sciences|December 18, 2012
Preclinical Determinants of Drug Choice under Concurrent Schedules of Drug Self-AdministrationMatthew L Banks, S Stevens Negus
Neuropharmacology|June 11, 2013
Environmental modulation of drug taking: Nonhuman primate models of cocaine abuse and PET neuroimagingMichael A Nader, Matthew L Banks
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2021
Adding dopamine to the complexity of sex differences in opioid reinforcementHannah L Robinson, Matthew L Banks
Experimental and Clinical Psychopharmacology|April 23, 2019
Effects of repeated kappa-opioid receptor agonist U-50488 treatment and subsequent termination on intracranial self-stimulation in male and female ratsKaycee E Faunce, Matthew L Banks
Cold Spring Harbor Perspectives in Medicine|November 6, 2012
Medications development for opioid abuseS Stevens Negus, Matthew L Banks
Psychopharmacology|June 20, 2023
Effects of environmental and pharmacological manipulations on cocaine-vs-negative reinforcer choice in male and female ratsMadison M Marcus, Matthew L Banks
Experimental and Clinical Psychopharmacology|December 19, 2017
Remifentanil maintains lower initial delayed nonmatching-to-sample accuracy compared to food pellets in male rhesus monkeysBlake A Hutsell, Matthew L Banks
Pharmacology, Biochemistry, and Behavior|April 27, 2017
Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications developmentS Stevens Negus, Matthew L Banks
Addiction Biology|February 21, 2024
The dopamine 3 receptor as a candidate biomarker and therapeutic for opioid use disorderMatthew L Banks, Jon E Sprague
Drug and Alcohol Dependence|March 26, 2026
Effects of nonpharmacological manipulations and repeated xanomeline treatment on methamphetamine-vs-food choice in Sprague Dawley and Long Evans ratsAmber N Baldwin, Matthew L Banks
Pageof 15